Small Molecules in Oncology

Specificaties
Paperback, 238 blz. | Engels
Springer Berlin Heidelberg | 2010e druk, 2012
ISBN13: 9783642261459
Rubricering
Springer Berlin Heidelberg 2010e druk, 2012 9783642261459
Onderdeel van serie Recent Results in Cancer Research
€ 226,69
Levertijd ongeveer 9 werkdagen
Gratis verzonden

Samenvatting

Extensive research into the molecular mechanisms of cancer disease has heralded a new age of targeted therapy. In malignant cells, key proteins that are crucial to tumor growth and survival are now being targeted directly with rationally designed inhibitors. Apart from monoclonal antibodies, small molecule therapeutics such as oncogenic protein kinase inhibitors are attracting a vast amount of investigational attention. This textbook, written by acknowledged experts, provides a broad overview of the small molecules currently used for the treatment of malignant diseases and discusses interesting novel compounds that are in the process of clinical development to combat cancer.

Specificaties

ISBN13:9783642261459
Taal:Engels
Bindwijze:paperback
Aantal pagina's:238
Uitgever:Springer Berlin Heidelberg
Druk:2010

Inhoudsopgave

Protein kinase inhibitors.- Imatinib Mesylate.- Erlotinib.- Axitinib (AG-013736).- Lapatinib.- Sorafenib.- Sunitinib.- Dasatinib.- Nilotinib.- Bosutinib.- Epigenetic modifiers.- Decitabine.- 5-Azacytidine/Azacitidine.- Cell cycle inhibitors.- Bortezomib.- Temsirolimus.- Danusertib (formerly PHA-739358) – A Novel Combined Pan-Aurora Kinases and Third Generation Bcr-Abl Tyrosine Kinase Inhibitor.- BI_2536 - Targeting the Mitotic Kinase Polo-Like Kinase 1 (Plk1).- Other novel agents.- Imetelstat (GRN163L) - Telomerase-Based Cancer Therapy.- GDC-0449 - Targeting the Hedgehog Signaling Pathway.
€ 226,69
Levertijd ongeveer 9 werkdagen
Gratis verzonden

Rubrieken

    Personen

      Trefwoorden

        Small Molecules in Oncology